Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Penumbra Inc One Penumbra Place Alameda CA 94502 USA

P: 510-748-3200 F: +61 862634444

Description:

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Key Statistics

Overview:

Market Capitalization, $K 10,475,079
Shares Outstanding, K 36,449
Annual Sales, $ 560,410 K
Annual Net Income, $ -15,700 K
Last Quarter Sales, $ 166,900 K
Last Quarter Net Income, $ 3,650 K
60-Month Beta 0.23
% of Insider Shareholders 8.90%
% of Institutional Shareholders 93.72%
Float, K 33,205
% Float 91.10%

Growth:

1-Year Return 58.70%
3-Year Return 130.37%
5-Year Return 423.29%
5-Year Revenue Growth 201.13%
5-Year Earnings Growth 37.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.10 on 02/23/21
Next Earnings Date 05/04/21
Earnings Per Share ttm 0.18
EPS Growth vs. Prev Qtr 600.00%
EPS Growth vs. Prev Year 90.91%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PEN Ratios

Ratio
Price/Earnings ttm 1,590.78
Price/Earnings forward 532.53
Price/Earnings to Growth 12.21
Return-on-Equity % 1.17%
Return-on-Assets % 0.90%
Profit Margin % -2.80
Net Margin % N/A
Debt/Equity 0.04
Price/Sales 18.62
Price/Cash Flow 536.50
Price/Book 16.30
Book Value/Share 17.57
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar